STOCK TITAN

Anterix Inc. SEC Filings

ATEX NASDAQ

Welcome to our dedicated page for Anterix SEC filings (Ticker: ATEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.

The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.

Rhea-AI Summary

Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe exercised stock options and sold common stock in a series of transactions dated June 15, 2026. She exercised options covering 29,368 shares of common stock at strike prices of $34.96 and $49.39 per share.

To pay the exercise prices and related taxes on a cashless basis, the issuer withheld a total of 15,657 shares at $82.50 per share, which the filing clarifies did not involve open‑market sales. Ashe also completed open‑market sales totaling 17,711 shares at weighted average prices of about $81.04 and $82.14 per share. One reported sale left her with 9,531 shares held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Anterix Inc. President and CEO Scott A. Lang exercised stock options and settled related obligations in shares. On June 15, 2026, he exercised options to acquire 63,788 shares at $30.99 per share and 74,530 shares at $34.96 per share. The company withheld 39,621 and 48,470 shares, respectively, to pay the exercise prices and cover income tax withholding, which the filing states did not involve any open market sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Anterix Inc. director Mark Fleischhauer reported an open-market sale of 3,500 shares of Common Stock on June 15, 2026 at an average price of $79.8294 per share. Following this transaction, he directly holds 12,769 Anterix common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Anterix Inc. director Mahvash Yazdi reported selling 7,000 shares of Common Stock at $80.00 per share in an open-market transaction. After this sale, she directly holds 19,407 shares. She also indirectly holds 750 shares through a 401(k) and 250 shares through the Yazdi Family Trust, where she serves as trustee and disclaims beneficial ownership beyond her pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The filing is a Form 144 notice reporting proposed sales of Common stock by an issuer-affiliated account and related option exercise activity. The entry list shows multiple restricted stock entries and a Stock Option Exercise on 06/17/2026 with a quantity of 1,226 shares; other listed quantities include 554, 459, 541, 905 and 606 shares tied to various grant or vesting dates.

The header also includes numeric fields shown as 341134.50 and 18732889 alongside a broker address and the exchange NASDAQ; the document lists the broker as Morgan Stanley Smith Barney LLC. This filing reports planned dispositions and related issuer-side exercises/vesting; timing and full proceeds treatment are the items shown in the listed rows.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

ATEX submitted a Form 144 notice disclosing intended sales of Common Stock. The filing lists a stock option exercise line for 13,711 shares dated 06/15/2026 and two restricted stock entries of 1,250 shares (dated 05/17/2026) and 2,750 shares (dated 05/22/2026). The entries identify Morgan Stanley Smith Barney LLC as the broker and NASDAQ as the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Anterix Inc. reported a strong turnaround for fiscal 2026, posting net income of $90.6 million for the year ended March 31, 2026, compared with a prior-year loss. Full-year spectrum revenue was $6.5 million, while results were heavily supported by gains on spectrum-related intangible assets.

The company recorded a $105.4 million gain on exchange of intangible assets and a $34.8 million gain on sale of intangible assets for the year. At March 31, 2026, Anterix held $98.5 million in cash and cash equivalents, no debt, and total assets of $465.2 million.

Deferred revenue reached $161.2 million combined current and noncurrent, reflecting contracted future performance obligations. Anterix expects contracted customer cash proceeds of $25.3 million in fiscal 2027 and $23.4 million thereafter, and it has $226.7 million remaining under its share repurchase program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.72%
Tags
current report
Rhea-AI Summary

Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe reported a routine tax-related share withholding. On the transaction date, 2,501 shares of common stock were withheld by Anterix to cover withholding obligations tied to a partial vesting and settlement of restricted stock units, at an implied value of $60.00 per share. Following this non-market transaction, Ashe directly holds 13,531 shares of Anterix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Anterix (ATEX) SEC filings are available on StockTitan?

StockTitan tracks 77 SEC filings for Anterix (ATEX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Anterix (ATEX)?

The most recent SEC filing for Anterix (ATEX) was filed on June 17, 2026.